iShares MSCI Emerging Markets ETF (EEM) reached $71 on June 2 from a December 31 close of $55, marking a 29% year-to-date advance that surpassed the S&P 500 for the first time since 2021. Fidelity's Fundamental Emerging Markets ETF (FFEM) mirrored the move with a 30% gain, rising from roughly $13,000 per unit to a late-May peak near $43.45 before both funds surrendered 7% in five trading days. The inflows and subsequent volatility signal a tentative end to the three-year rotation away from emerging-market equity exposure that began when Fed tightening and dollar strength made developed-market carry trades the dominant play.

The last time emerging markets outran U.S. equities for a full year was 2021, when MSCI Emerging Markets returned -2.5% against the S&P's 26.9%—a relative victory only because the index fell less. The 2022-2024 period saw cumulative underperformance of 42 percentage points as rising U.S. real yields pulled capital toward short-dated Treasuries and mega-cap technology. This year's reversal follows two catalysts: a 15% decline in the dollar index from its October 2024 high and a shift in Chinese manufacturing PMI data that turned positive in March for the first time in eleven quarters. EEM's top five holdings—Alibaba, Tencent, Taiwan Semiconductor, Samsung, and Infosys—have each posted double-digit gains in local-currency terms, amplified by currency tailwinds in the rupee and won.

The 7% drawdown in early June exposes the fragility of the trade. Family offices that rotated in February are now facing the question of whether to scale during volatility or wait for confirmation that the Fed's next rate cycle favors risk-on positioning in emerging economies. The expense ratio on FFEM stands at 0.78%, meaningfully higher than EEM's 0.68%, but the fundamental-weighting methodology has delivered 120 basis points of annual alpha over the past decade in high-volatility regimes. DFA Emerging Markets Core Equity 2 Portfolio, with a 0.39% expense ratio, has gathered $1.2 billion in net inflows since January, suggesting institutional allocators are indexing the beta while hedging with active overlays.

Watch for June MSCI rebalancing flows and the next round of Chinese credit impulse data, both due before June 30. If the People's Bank of China extends its 500 billion yuan liquidity injection program beyond the current quarterly window, EEM could retest its June highs by mid-July. A reversal depends on whether the dollar index holds below 102 and U.S. two-year yields stay beneath 4.2%.

The three-year underperformance compressed valuations to 11.2x forward earnings by year-end 2024, the widest discount to the S&P 500 in eighteen years. That gap has narrowed to 8.4x as of June 6.